Cy5 tyramide
Example protocol
AT A GLANCE
- Fix/permeabilize/block cells or tissue
- Add primary antibody in blocking buffer
- Add HRP-conjugated secondary antibody
- Prepare tyramide working solution and apply in cells or tissue for 5-10 minutes at room temperature
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add an appropriate amount of DMSO to make a 1-5 mM tyramide stock solution.
Note: Make single-use aliquots and store unused 1000X stock solution at 2-8 °C, protected from light. Avoid repeat freeze-thaw cycles.
PREPARATION OF WORKING SOLUTION
Add 1 µL of the tyramide stock solution into 1 mL of a buffer of your choice containing 0.003% H2O2.
Note: For optimal performance, use Tris Buffer, pH=7.4.
Note: The tyramide working solution should be used immediately and made fresh on the day of use. Avoid direct exposure to light.
Make an appropriate concentration of secondary antibody-HRP working solution per the manufacturer's recommendations.
SAMPLE EXPERIMENTAL PROTOCOL
This protocol is applicable for both cells and tissues staining.
Fix the cells or tissue with 3.7% formaldehyde or paraformaldehyde, in PBS at room temperature for 20 minutes.
Rinse the cells or tissue with PBS twice.
Permeabilize the cells with 0.1% Triton X-100 solution for 1-5 minutes at room temperature.
Rinse the cells or tissue with PBS twice.
Deparaffinize and dehydrate the tissue according to the standard IHC protocols. Perform antigen retrieval with the preferred specific solution/protocol as needed. A protocol can be found at:
https://www.aatbio.com/resources/guides/paraffin-embedded-tissue-immunohistochemistry-protocol.html
Optional: Quench endogenous peroxidase activity by incubating cell or tissue sample in a peroxidase quenching solution (such as 3% hydrogen peroxide) for 10 minutes. Rinse with PBS twice at room temperature.
Optional: If using HRP-conjugated streptavidin, it is advisable to block endogenous biotins with biotin blocking buffer.
Block with preferred blocking solution (such as PBS with 1% BSA) for 30 minutes at 4 °C.
Remove the blocking solution and add the primary antibody diluted in the recommended antibody diluent for 60 minutes at room temperature or overnight at 4°C.
Wash with PBS three times for 5 minutes each.
Apply 100 µL of the secondary antibody-HRP working solution to each sample and incubate for 60 minutes at room temperature.
Note: Incubation time and concentration can be varied depending on the signal intensity.
Wash with PBS three times for 5 minutes each.
Prepare and apply 100 µL of the tyramide working solution to each sample and incubate for 5-10 minutes at room temperature.
Note: If you observe a non-specific signal, you can shorten the incubation time with the tyramide reagent. You should optimize the incubation period using positive and negative control samples at various incubation time points. Or you can use a lower concentration of the tyramide reagent in the working solution.
Rinse with PBS three times.
Counterstain the cell or tissue samples as needed. AAT provides a series of nucleus counterstain reagents as listed in Table 1. Follow the instructions provided with the reagents.
Mount the coverslip using a mounting medium with anti-fading properties.
Note: To ensure optimal results, it is recommended to use either ReadiUse™ microscope mounting solution (Cat. 20009) or FluoroQuest™ TSA/PSA Antifade Mounting Medium *Optimized for Tyramide and Styramide Imaging* (Cat. 44890) instead of Vectashield® mounting media. There are instances where Vectashield® mounting media may not be suitable for certain TSA/PSA conjugates.
Use the appropriate filter set to visualize the signal from the tyramide labeling.
Table 1. Products recommended for nucleus counterstain.
Cat# | Product Name | Ex/Em (nm) |
17548 | Nuclear Blue™ DCS1 | 350/461 |
17550 | Nuclear Green™ DCS1 | 503/526 |
17551 | Nuclear Orange™ DCS1 | 528/576 |
17552 | Nuclear Red™ DCS1 | 642/660 |
Calculators
Common stock solution preparation
0.1 mg | 0.5 mg | 1 mg | 5 mg | 10 mg | |
1 mM | 112.36 µL | 561.798 µL | 1.124 mL | 5.618 mL | 11.236 mL |
5 mM | 22.472 µL | 112.36 µL | 224.719 µL | 1.124 mL | 2.247 mL |
10 mM | 11.236 µL | 56.18 µL | 112.36 µL | 561.798 µL | 1.124 mL |
Molarity calculator
Mass (Calculate) | Molecular weight | Volume (Calculate) | Concentration (Calculate) | Moles | ||||
/ | = | x | = |
Spectrum
Product family
Name | Excitation (nm) | Emission (nm) | Extinction coefficient (cm -1 M -1) | Quantum yield | Correction Factor (260 nm) | Correction Factor (280 nm) | Correction Factor (482 nm) | Correction Factor (565 nm) |
Cy5 tertrazine [Cy5 tertrazine] | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 | 0.009 | 0.09 |
Cy5 phosphoramidite | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 | 0.009 | 0.09 |
Cy5 tetrazine | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 | 0.009 | 0.09 |
Cy5 aldehyde | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 | 0.009 | 0.09 |
DBCO-Cy5 | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 | 0.009 | 0.09 |
Cy3 tyramide | 555 | 569 | 1500001 | 0.151 | 0.07 | 0.073 | - | - |
Cy7 tyramide | 756 | 779 | 250000 | 0.3 | 0.05 | 0.036 | 0.0005 | 0.0193 |
XFD514 tyramide | 518 | 543 | 80000 | - | 0.31 | 0.18 | - | - |
XFD532 tyramide | 534 | 553 | 81000 | 0.611 | 0.24 | 0.09 | - | - |
Show More (1) |
Citations
Authors: Chen, Fangfang and Li, Yixuan and Zhao, Li and Lin, Cong and Zhou, Yingzi and Ye, Wenjing and Wan, Weiguo and Zou, Hejian and Xue, Yu
Journal: International Immunopharmacology (2024): 112942
Authors: Jiang, Hongjing and Sun, Xuheng and Wu, Yindi and Xu, Jianyi and Xiao, Cong and Liu, Qing and Fang, Lijun and Liang, Yuanfeng and Zhou, Jiahui and Wu, Yueheng and others,
Journal: Materials Today Bio (2024): 101151
Authors: Li, Han and Yang, Zhen and Liang, Wukaiyang and Nie, Hao and Guan, Yuqi and Yang, Ni and Ji, Tianyi and Liu, Yu and Huang, Yi and Zhang, Le and others,
Journal: The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences (2024): glae059
Authors: Tang, Yang and Wei, Jingsun and Ge, Xiaoxu and Yu, Chengxuan and Lu, Wei and Qian, Yucheng and Yang, Hang and Fu, Dongliang and Fang, Yimin and Zhou, Yinyi and others,
Journal: Cancer Letters (2024): 216798
References
Authors: Faget L, Hnasko TS.
Journal: Methods Mol Biol (2015): 161
Authors: Trang NT, Hirai T, Ngan PH, Lan NT, Fuke N, Toyama K, Yamamoto T, Yamaguchi R.
Journal: J Vet Diagn Invest (2015): 326
Authors: Garrigues HJ, Rubinchikova YE, Rose TM.
Journal: Virology (2014): 75
Authors: Lauter G, Soll I, Hauptmann G.
Journal: Methods Mol Biol (2014): 175
Authors: Stack EC, Wang C, Roman KA, Hoyt CC.
Journal: Methods (2014): 46